Mankind Pharma Ltd (MANKIND) — Cash Flow-to-Debt Ratio
Mankind Pharma Ltd (MANKIND) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2023, meaning its operating cash flow of Rs1.93 Billion could theoretically repay 0% of its total liabilities (Rs24.65 Billion) in one year. Check MANKIND capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mankind Pharma Ltd Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Mankind Pharma Ltd across 7 annual periods. Also explore Mankind Pharma Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Mankind Pharma Ltd (2019–2025)
Year-by-year debt coverage analysis for Mankind Pharma Ltd. For market capitalisation and broader financial context, see Mankind Pharma Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.7% |
| 2024 | 0.90x | Rs21.52 Billion | Rs23.87 Billion | ▲ +2.8% |
| 2023 | 0.88x | Rs18.13 Billion | Rs20.67 Billion | ▲ +170.1% |
| 2022 | 0.32x | Rs9.20 Billion | Rs28.31 Billion | ▼ -56.9% |
| 2021 | 0.75x | Rs11.37 Billion | Rs15.10 Billion | ▼ -1.3% |
| 2020 | 0.76x | Rs10.70 Billion | Rs14.02 Billion | ▲ +43.7% |
| 2019 | 0.53x | Rs6.00 Billion | Rs11.31 Billion | — |